홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

HCID 1388
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
28289-54-5
표준 SMILES
CN1CC=C(c2ccccc2)CC1
InChIKey
PLRACCBDVIHHLZ-UHFFFAOYSA-N
분자식
C12H15N
평균 분자량
173.25 g/mol
단동위원소 질량
173.12044948

개요

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4. It has a role as a neurotoxin. It is a member of methylpyridines, a tetrahydropyridine and a phenylpyridine.

이름 및 식별자

우선 이름
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
IUPAC
1-methyl-4-phenyl-3,6-dihydro-2H-pyridine
영어명
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
분자식
C12H15N
분자량
173.25

이름 및 동의어

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine28289-54-5MPTPPYRIDINE, 1,2,3,6-TETRAHYDRO-1-METHYL-4-PHENYL-1,2,3,6-Tetrahydro-1-methyl-4-phenylpyridineDTXSID8040933N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine9P21XSP91PNSC-139654CHEBI:17963RefChem:76325DTXCID6020933
이름 더 보기
NSC 139654Naphthoic Acid Impurity 1111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridin1,2,3,6-tetrahydro-1-methyl-4-phenyl-pyridin1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDRO-PYRIDINEN-METHYL-4-PHENYL-1,2,3,6-TETRAHYDRO-PYRIDINE
248-939-71-methyl-4-phenyl-3,6-dihydro-2H-pyridine1-METHYL-4-PHENYL-PIPERIDINE-3-ENCCRIS 2186HSDB 6942CHEMBL241721-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine1-Methyl-4-phenyl-1,2,3,6-tetrahydroxpyridine

데이터베이스 식별자

CAS
28289-54-5

물성

구조 계산 물성보충 중

XLogP
2.7
극성 표면적
3.2 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
1
회전 가능 결합 수
1
무거운 원자 수
13
형식 전하
0
복잡도
189

실험 및 물리화학적 성질

Chemical ClassesNitrogen Compounds -> Pyridines
DrugsDEA NFLIS-Drug Category -> Narcotics
LogPlog Kow = 2.71 @ pH 7.5 (as MPP+)
Color/FormCrystals from heptane
Boiling Point85 to 90 °C @ 0.8 mm Hg
Melting Point40-42 °C
Vapor Pressure0.00945 [mmHg]
Physical DescriptionCrystals; [HSDB]

물리화학적 성질

녹는점
36 °C · aprox. 36°C
끓는 점
128 · 128-132 °C12 mm Hg(lit.)
밀도
1.001 · 1.001±0.06 g/cm3(Predicted)
저장 조건
Inert atmosphere,Room Temperature
용해도
클로로포름(약간 용해됨), 디클로로메탄(약간 용해됨), 아세트산에틸(약간 용해됨)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P260, P264, P270, P301+P316, P308+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazards Summary · 1건

The toxic effects of MPTP were discovered in 1982 when several injection drug users in San Jose, California developed frozen addict syndrome within a week of using MPPP contaminated with MPTP. The syndrome resembled idiopathic Parkinson disease, and patients showed some improvement after treatment with L-dopa. [Ford, p. 634-5] MPTP does not cause occupational parkinsonism, but it causes acute parkinsonism in humans and experimental animals after injection. The cumulative doses in animals are in the range of 1.5 to 410 mg/kg depending on the species. [See Reference #1}

Hazard Classes and CategoriesAcute Tox. 3 (100%)

안전 및 보호

Disposal Methods · 1건

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

독성 정보

Treatment · 1건

Because MPTP itself is not directly harmful, toxic effects of acute MPTP poisoning can be mitigated by the administration of monoamine oxidase inhibitors (MAOIs) such as selegiline. MAOIs prevent the metabolism of MPTP to MPP+ by inhibiting the action of MAO-B, minimizing toxicity and preventing neural death. (L1670)

화학 및 산업

약리 정보

Metabolism/Metabolites · 2건

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has known human metabolites that include p-hydroxy-MPTP and 1-methyl-4-phenylpyridin-1-ium.

In the brain, MPTP is metabolized into the toxic cation 1-methyl-4-phenylpyridinium (MPP+) by the enzyme MAO-B of glial cells. (L1670)

MeSH Pharmacological Classification · 2건

Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept.

Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

용도 및 제조

Uses · 2건

A contaminant produced during the synthesis of MPPP, a synthetic heroin; it causes irreversible parkinsonism in primates and is used in research laboratories; MPTP is converted to the toxic metabolite MPP+ in the brain where it selectively destroys cells in the substantia nigra. [Merck Index #6294]

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes permanent symptoms of Parkinson's disease by killing certain neurons in the substantia nigra of the brain. MPTP can be accidentally produced during the illicit manufacture of MPPP, and that is how its Parkinson-inducing effects were first discovered. MPTP is used to recreate and study the Parkinson's disease in experimental animal models.

Methods of ManufacturingPrepn as hydrochloride by Grignard reaction: A Ziering et al, J Org Chem 12, 894 (1947). Alternative prepn: CJ Schmidle, RC Mansfield, J Am Chem Soc 78, 425 (1956).
General Manufacturing InformationIdentification as impurity in "synthetic heroin".

응용 분야

관련 반응

9건
반응 기록 만들기
HRID 225222 반응식
HRID 225222반응물로
HRID 669905 반응식
HRID 669905생성물로
HRID 1277525 반응식
HRID 1277525반응물로
HRID 1568962 반응식
HRID 1568962반응물로
HRID 1980093 반응식
HRID 1980093반응물로
HRID 2134151 반응식
HRID 2134151반응물로
HRID 2150391 반응식
HRID 2150391반응물로
HRID 2163137 반응식
HRID 2163137생성물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
PubChem CID
1388
DTXSID
DTXSID8040933
ChEMBL
CHEMBL24172
ChEBI
CHEBI:17963
UNII
9P21XSP91P
EC Number
248-939-7
Nikkaji
J22.909A
산도 계수 (pKa)
8.66 · 8.66±0.40(Predicted)
물리적 상태
고체
색상
연한 노란색에서 밝은 노란색까지
Merck
13 · 13,6319
안정성
안정적인. 강한 산화제와 호환되지 않습니다.

화학적 성질

Light Yellow Solid

Adverse EffectsNeurotoxin - Parkinsonism
Toxicity Summary · 1건

MPTP itself is not toxic, and as a lipophilic compound can cross the blood-brain barrier. Once inside the brain, MPTP is metabolized into the toxic cation 1-methyl-4-phenylpyridinium (MPP+) by the enzyme MAO-B of glial cells. MPP+ primarily kills dopamine-producing neurons in a part of the brain called the pars compacta of the substantia nigra. MPP+ interferes with complex I of the electron transport chain, a component of mitochondrial metabolism, which leads to cell death and causes the buildup of free radicals, toxic molecules that contribute further to cell destruction. (L1670)

Human Toxicity Excerpts · 1건

chemical selective damage to cells in the substantia nigra occurs following human ingestion of MPTP (1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine). ... Following iv injection of an illicit drug containing MPTP, humans developed chronic Parkinsonism, resulting from substantia nigra destruction.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Antidote and Emergency Treatment · 2건

/SRP:/ Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in respiratory arrest. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Watch for signs of fluid overload. Consider drug therapy for pulmonary edema ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam (Valium) ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poison A and B/

Toxicity DataLD50: 54 mg/kg (Subcutaneous, Mouse) (A2830)

안전 데이터

wgk
3
rtecs
UT8358900
ridadr
UN 2811 6.1/PG 2
독성
Human toxicity originally discovered when it was an unexpected by-product from the illicit synthesis of a heroin substitute (i.e., meperidine analog). Currently used experimentally as the primary animal model for the study of Parkinson’s disease. MPTP is a neurotoxicant that is activated to 1-methyl-4-phenylpyridinium ion (MPP1) by the actions of monoamine oxidase B located in the mitochondria of brain astrocytes. The MPP1 is then transported into dopamine, and to a lesser extent, other monoaminergic neurons. Once inside these dopamine neurons in the substantia nigra, it destroys these neurons by mechanisms that may involve an oxidative cascade and/or inhibition of electron transport. Intoxication causes a parkinsonism syndrome almost identical in signs and symptoms to Parkinson’s disease, including rigidity, bradykinesia, tremor, and postural instability. In the event of known ingestion, immediate (but not delayed) administration of a monoamine oxidase inhibitor (especially one selective for MAO-B like deprenyl) and dopamine uptake inhibitor can be therapeutic.
risk_code
25-39/23/24/25
hazard_code
T
safety_code
45
포장분류
III
위험 등급
6.1(b)
유해 물질 데이터
28289-54-5(Hazardous Substances Data)

용도1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a dopaminergic neurotoxin that reportedly causes a severe and irreversible Parkinsonian condition in humans and monkeys.

추가 설명

정의ChEBI: A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.